Estimating Long-Term Survivorship Rates Among Patients With Resected Stage III/IV Melanoma: Analyses From CheckMate 238 and European Organization for Research and Treatment of Cancer 18071 Trials
Bristol-Myers Squibb
Jeffrey S Weber; Mark R Middleton; Georgia Yates; Daniel J Sharpe; Murat Kurt; Maurice Lobo; Andriy Moshyk; Jacqueline Vanderpuye-Orgle; Peter Mohr